| Literature DB >> 32704306 |
Alireza Khatami1, Ali Pormohammad2, Rana Farzi3, Hassan Saadati4, Maryam Mehrabi5, Seyed Jalal Kiani1, Saied Ghorbani1,6.
Abstract
BACKGROUND: Breast cancer is reported as one of the most common cancers among females worldwide. Infectious agents especially viruses have been considered as role players in the development of breast cancer. Although some investigations suggest an association between bovine leukemia virus (BLV) and breast cancer, the involvement of this virus as a risk factor remains controversial. The present study aimed to find out any possible association between BLV and breast cancer through conducting a systematic review and meta-analysis.Entities:
Keywords: BLV; Bovine leukemia virus; Breast cancer; Meta-analysis
Year: 2020 PMID: 32704306 PMCID: PMC7374970 DOI: 10.1186/s13027-020-00314-7
Source DB: PubMed Journal: Infect Agent Cancer ISSN: 1750-9378 Impact factor: 2.965
Characteristics of studies included in the current study
| study | Publication year | Sample collection date | country | continent | Study-design | Sample type | Detection target | Case | Case positive | Control | Control positive | Detection method | Age control | Age case | NOS score | ref |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Giovanna | 2013 | Since 2006 | Colombia | South America | Case–control | FFPE | Gag | 53 | 19 | 53 | 24 | PCR | 52.2 | 46.4 | 8 | [ |
| Schwingel | 2019 | 2015–2017 | Brazil | South America | Case–control | FFPE | Tax | 72 | 22 | 72 | 10 | Nested PCR | 38 | 52.5 | 9 | [ |
| Buehring | 2007 | NR | US | North America | Case–control | FFPE | Tax | 110 | 65 | 103 | 30 | In situ PCR | NR | NR | 9 | [ |
| Buehring | 2015 | 2002–2008 | US | North America | Case–control | FFPE | Tax | 114 | 67 | 104 | 30 | In situ PCR | 48.7 | 55.9 | 9 | [ |
| Baltzell | 2017 | 2009–2011 | US | North America | Case–control | FFPE | Tax | 61 | 35 | 103 | 20 | In situ PCR | 54.4 | 54.59 | 9 | [ |
| Buehring | 2017 | 1995–2010 | Australia | ocenia | Case–control | FFPE | Tax | 50 | 40 | 46 | 19 | In situ PCR | 49.59 | 55.08 | 9 | [ |
| Lawson and Glenn | 2017 | NR | Australia | ocenia | Case–control | FFPE | Tax | 22 | 20 | 17 | 6 | In situ PCR | 36.4 | 56.1 | 8 | [ |
| Khalilian | 2019 | 2017–2018 | Iran | Middle East | Case–control | FFPE and Blood | Tax | 172 | 52 | 200 | 60 | In situ PCR | 47.5 | 53 | 9 | [ |
| Khalilian | 2019 | 2017–2018 | Iran | Middle east | Case–control | FFPE and Blood | Gag | 172 | 14 | 200 | 16 | Nested PCR | 47.5 | 53 | 8 | [ |
FFPE Formalin-fixed paraffin-embedded, PCR Polymerase chain reaction, NOS Newcastle- Ottawa assessment scale
Fig. 1PRISMA flowchart of included studies
The result of meta-regressions
| Variables | Coefficient | Standard error | T | p value | Lower 95% | Upper 95% |
|---|---|---|---|---|---|---|
| Sample type | 0.07 | 1.38 | 0.05 | 0.96 | −3.78 | 3.92 |
| Detection target | −1.35 | 0.68 | −1.98 | 0.11 | −3.24 | 0.54 |
| Detection method | 0.23 | 0.66 | 0.35 | 0.74 | −1.61 | 2.07 |
| Sample size | 0.004 | 0.005 | −0.79 | 0.47 | −0.02 | 0.01 |
Fig. 2Association between BLV and breast cancer risk in case-control studies based on detection-target
Association between breast cancer and BLV detection-target gene
| Gene target | No of studies | Odds ratio (95%Cl) | Heterogeneity chi squared | Odds ratio two-tailed p value | Heterogeneity test, |
|---|---|---|---|---|---|
| Gag | 2 | 0.84 (0.49–1.44) | 0.56 | 0.51 | 0.45 |
| Tax | 7 | 3.54 (1.92–6.52) | 31.64 | < 0.001 | < 0.001 |
| total | 9 | 2.57 (1.92–6.52) | 46.62 | 0.001 | < 0.001 |
Fig. 3Funnel plot for estimation of publication bias